Newsbenzinga
Immunome Announces First Patient Dosed In Phase 1 IM-3050 Trial To Treat FAP-Expressing Advanced Solid Tumors
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…